|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1104080854 |
003 |
OCoLC |
005 |
20231120010356.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
190608s2019 enka ob 001 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e rda
|e pn
|c EBLCP
|d N$T
|d OPELS
|d EBLCP
|d OCLCF
|d YDX
|d OCLCQ
|d TXM
|d OCLCO
|d CUS
|d UKAHL
|d OCLCQ
|d OCL
|d OCLCA
|d OCLCQ
|d ERF
|d NRC
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9780128163795
|q (electronic bk.)
|
020 |
|
|
|a 0128163798
|q (electronic bk.)
|
020 |
|
|
|z 9780128161470
|
035 |
|
|
|a (OCoLC)1104080854
|
050 |
|
4 |
|a RM301.25
|
060 |
|
4 |
|a WH 200
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.19
|2 23
|
100 |
1 |
|
|a Rai, Geeta,
|e author.
|
245 |
1 |
0 |
|a NETosis :
|b immunity, pathogenesis and therapeutics /
|c Geeta Rai.
|
264 |
|
1 |
|a London :
|b Elsevier,
|c [2019]
|
264 |
|
4 |
|c �2019
|
300 |
|
|
|a 1 online resource (202 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed June 12, 2019)
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Neutrophil extracellular trap formation: an introduction -- NETosis: mechanisms and antimicrobial strategies -- Factors regulating NETosis -- NETosis in neonates -- NETosis in autoimmunity -- NETosis in other diseases and therapeutic approaches.
|
520 |
|
|
|a NETosis: Immunity, Pathogenesis and Therapeutics takes a focused approach to the clinical aspects of NETosis and drug development, bringing critical findings. Chapters introduce NETosis, consider mechanisms and antimicrobial strategies regulating NETosis, examine NETosis in neonates, explore the role of NETosis in autoimmunity, delve into NETosis and other diseases, and present therapeutic approaches for dysregulated NETosis. Since Brinkamm, et al, discovered an unrecognized neutrophil anti-microbial mechanism responsible for the extracellular killing of invading pathogens in 2004, the novel process in which nuclear chromatin de-condenses and DNA is ejected into the extra cellular environment, trapping and inactivating tissue pathogens has rapidly evolved.
|
650 |
|
0 |
|a Neutrophils
|x Immunology.
|
650 |
|
0 |
|a Cell death.
|
650 |
|
0 |
|a Drug development.
|
650 |
|
2 |
|a Neutrophils
|x immunology
|0 (DNLM)D009504Q000276
|
650 |
|
6 |
|a Neutrophiles
|x Immunologie.
|0 (CaQQLa)201-0205557
|
650 |
|
6 |
|a Cellules
|x Mort.
|0 (CaQQLa)201-0110794
|
650 |
|
6 |
|a M�edicaments
|x D�eveloppement.
|0 (CaQQLa)201-0306620
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Neutrophils
|x Immunology
|2 fast
|0 (OCoLC)fst01036684
|
650 |
|
7 |
|a Cell death
|2 fast
|0 (OCoLC)fst00850180
|
650 |
|
7 |
|a Drug development
|2 fast
|0 (OCoLC)fst00898670
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/book/9780128161470/netosis
|z Texto completo
|